Amanta Healthcare Ltd
Mon 18/05/2026,15:40:3 | NSE : AMANTA
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 129.40
Previous Close
₹ 129.43
Volume
101274
Mkt Cap ( Rs. Cr)
₹488.55
High
₹ 129.40
Low
₹ 122.00
52 Week High
₹ 154.40
52 Week Low
₹ 92.00
Book Value Per Share
₹ 55.45
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Amanta Healthcare Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Amanta Healthcare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Amanta Healthcare - Monitoring Agency Report
-
Amanta Healthcare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Amanta Healthcare - Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended March 31,
-
Amanta Healthcare - Updates
-
Amanta Healthcare - Clarification Letter On Earlier Disclosure Submitted On April 18Th, 2026, Pursuant To SEBI (PIT) Regulati
-
Amanta Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Amanta Healthcare - Updates
-
Amanta Healthcare - Clarification On Earlier Disclosure Submitted On April 1St, 2026
-
Amanta Healthcare - Resignation
-
Amanta Healthcare - Announcement under Regulation 30 (LODR)-Change in Management
-
Amanta Healthcare - Disclosure under SEBI Takeover Regulations
-
Amanta Healthcare - Updates
-
Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Amanta Healthcare - Analysts/Institutional Investor Meet/Outcome
-
Amanta Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Amanta Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates
-
Amanta Healthcare - Updates
-
Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Amanta Healthcare - Updates
-
Amanta Healthcare - Open Market Purchase Of Equity Shares By Promoter
-
Amanta Healthcare - Trading Window
-
Amanta Healthcare - Updates
-
Amanta Healthcare - Open Market Purchase Of Equity Shares By Immediate Relative Of Director
-
Amanta Healthcare - Open Market Purchase Of Equity Shares By Promoter
-
Amanta Healthcare - Updates
Key fundamentals
Evaluate the intrinsic value of Amanta Healthcare Ltd stock
| Name | March-25 | March-24 | |||
|---|---|---|---|---|---|
| Assets | 291.3844 | 271.5179 | |||
| Liabilities | 291.3844 | 271.5179 | |||
| Equity | 28.8294 | 26.8294 | |||
| Gross Profit | 59.6685 | 57.49 | |||
| Net Profit | 10.5007 | 3.6332 | |||
| Cash From Operating Activities | 46.62 | 58.073 | |||
| NPM(%) | 3.82 | 1.29 | |||
| Revenue | 274.7082 | 280.3403 | |||
| Expenses | 215.0397 | 222.8503 | |||
| ROE(%) | 4.87 | 1.68 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Amanta Healthcare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 708.95 | -1.65 | 0.00 | 74.08 | -26.19 | 0.71 |
| Lotus Eye Hospital and Institute Ltd | 104.74 | -1.71 | 337.87 | 269.94 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 7.00 | -0.99 | 0.00 | 1693.40 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 754.75 | 11.68 | 0.00 | 254.56 | -363.15 | 0.00 |
Company Info
Our Company was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership firm "Marck Parenterals (India)" under Part IX of the Companies Act, 1956 and received the Certificate for Commencement of Business on January 06, 1995. The name of our Company was changed to "Marck Biosciences Limited" pursuant to a special resolution passed by our shareholders on October 29, 2005, and a fresh certificate of incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005. Subsequently, the name of our Company was changed to "Amanta Healthcare Limited" pursuant to a special resolution passed by our shareholders on June 12, 2014, and a fresh certificate of incorporation dated June 24, 2014 issued by the Registrar of Companies, Gujarat, at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line "LVP Line II" for the manufacture of Large Volume Parenterals in Kheda, Gujarat2005- Launched a specialised production line "SVP Line I" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line "SVP line II" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.- Approval from The National Pharmaceutical Control Bureau - Malaysia (a PIC member)2021- Launched a specialised production line "SteriPort -Debottlenecking"2023- Received WHO- GMP certification for Manufacturing facility at Kheda, Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)
Our Company was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership firm "Marck Parenterals (India)" under Part IX of the Companies Act, 1956 and received the Certificate for Commencement of Business on January 06, 1995. The name of our Company was changed to "Marck Biosciences Limited" pursuant to a special resolution passed by our shareholders on October 29, 2005, and a fresh certificate of incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005. Subsequently, the name of our Company was changed to "Amanta Healthcare Limited" pursuant to a special resolution passed by our shareholders on June 12, 2014, and a fresh certificate of incorporation dated June 24, 2014 issued by the Registrar of Companies, Gujarat, at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line "LVP Line II" for the manufacture of Large Volume Parenterals in Kheda, Gujarat2005- Launched a specialised production line "SVP Line I" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line "SVP line II" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.- Approval from The National Pharmaceutical Control Bureau - Malaysia (a PIC member)2021- Launched a specialised production line "SteriPort -Debottlenecking"2023- Received WHO- GMP certification for Manufacturing facility at Kheda, Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)
Read More
Parent Organisation
Amanta Healthcare Ltd.
Founded
21/12/1994
Managing Director
Mr.Bhavesh Patel
NSE Symbol
AMANTAEQ
FAQ
The current price of Amanta Healthcare Ltd is ₹ 125.82.
The 52-week high for Amanta Healthcare Ltd is ₹ 129.40 and the 52-week low is ₹ 122.00.
The market capitalization of Amanta Healthcare Ltd is currently ₹ 488.55. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Amanta Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Amanta Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Amanta Healthcare Ltd shares.
The CEO of Amanta Healthcare Ltd is Mr.Bhavesh Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
